Sartorius Stedim Biotech Stock Total Asset
SDMHF Stock | USD 220.00 4.44 1.98% |
Sartorius Stedim Biotech fundamentals help investors to digest information that contributes to Sartorius Stedim's financial success or failures. It also enables traders to predict the movement of Sartorius Pink Sheet. The fundamental analysis module provides a way to measure Sartorius Stedim's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Sartorius Stedim pink sheet.
Sartorius |
Sartorius Stedim Biotech Company Total Asset Analysis
Sartorius Stedim's Total Asset is everything that a business owns. It is the sum of current and long-term assets owned by a firm at a given time. These assets are listed on a balance sheet and typically valued based on their purchasing prices, not the current market value.
Current Sartorius Stedim Total Asset | 3.95 B |
Most of Sartorius Stedim's fundamental indicators, such as Total Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Sartorius Stedim Biotech is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Total Asset is typically divided on the balance sheet on current asset and long-term asset. Long-term is the value of company property and other capital assets that are expected to be useable for more than one year. Long term assets are reported net of depreciation. On the other hand current assets are assets that are expected to be sold or converted to cash as part of normal business operation.
Competition |
Based on the latest financial disclosure, Sartorius Stedim Biotech has a Total Asset of 3.95 B. This is 47.46% lower than that of the Healthcare sector and 19.29% higher than that of the Medical Instruments & Supplies industry. The total asset for all United States stocks is 86.59% higher than that of the company.
Sartorius Total Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Sartorius Stedim's direct or indirect competition against its Total Asset to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Sartorius Stedim could also be used in its relative valuation, which is a method of valuing Sartorius Stedim by comparing valuation metrics of similar companies.Sartorius Stedim is currently under evaluation in total asset category among related companies.
Sartorius Fundamentals
Return On Equity | 0.33 | |||
Return On Asset | 0.14 | |||
Profit Margin | 0.20 % | |||
Operating Margin | 0.30 % | |||
Current Valuation | 32.97 B | |||
Shares Outstanding | 92.17 M | |||
Shares Owned By Insiders | 73.81 % | |||
Shares Owned By Institutions | 13.73 % | |||
Price To Earning | 60.34 X | |||
Price To Book | 13.58 X | |||
Price To Sales | 9.62 X | |||
Revenue | 2.89 B | |||
Gross Profit | 1.55 B | |||
EBITDA | 798.67 M | |||
Net Income | 414.41 M | |||
Cash And Equivalents | 161.7 M | |||
Cash Per Share | 1.75 X | |||
Total Debt | 521.07 M | |||
Debt To Equity | 0.50 % | |||
Current Ratio | 1.49 X | |||
Book Value Per Share | 24.67 X | |||
Cash Flow From Operations | 695.97 M | |||
Earnings Per Share | 7.94 X | |||
Price To Earnings To Growth | 3.43 X | |||
Number Of Employees | 10.41 K | |||
Beta | 0.45 | |||
Market Capitalization | 34.9 B | |||
Total Asset | 3.95 B | |||
Z Score | 39.6 | |||
Annual Yield | 0 % | |||
Five Year Return | 0.50 % | |||
Net Asset | 3.95 B |
About Sartorius Stedim Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Sartorius Stedim Biotech's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Sartorius Stedim using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Sartorius Stedim Biotech based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sartorius Stedim Biotech. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in rate. Note that the Sartorius Stedim Biotech information on this page should be used as a complementary analysis to other Sartorius Stedim's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Complementary Tools for Sartorius Pink Sheet analysis
When running Sartorius Stedim's price analysis, check to measure Sartorius Stedim's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sartorius Stedim is operating at the current time. Most of Sartorius Stedim's value examination focuses on studying past and present price action to predict the probability of Sartorius Stedim's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sartorius Stedim's price. Additionally, you may evaluate how the addition of Sartorius Stedim to your portfolios can decrease your overall portfolio volatility.
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |